GlassScriptPhysician profile
Andrew M Strang
NPI 1548470800
$5,093.56
in general payments reported to CMS, 2019-2025
43 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $240 · 2021: $636 · 2022: $539 · 2023: $659 · 2024: $934 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,588 · Travel and Lodging: $714 · Education: $3.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,587.77 |
| Travel and Lodging | $713.97 |
| Education | $3.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $982.95 | 2025 | Bioprotect Balloon Implant System |
| Procept Biorobotics Corporation | $740.89 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Urogen Pharma, INC. | $266.35 | 2021-2025 | Jelmyto |
| Abbvie INC. | $247.52 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $230.21 | 2021-2025 | Erleada |
| Antares Pharma, INC. | $197.55 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $197.48 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $178.45 | 2021-2025 | Prolaris |
| Allergan, INC. | $172.94 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $172.24 | 2019-2022 | |
| Baxter Healthcare | $161.59 | 2019-2022 | |
| Astellas Pharma US INC | $159.75 | 2019-2025 | Xtandi |
| Pfizer INC. | $128.80 | 2019-2025 | |
| Medtronic, INC. | $119.06 | 2021-2022 | |
| Boston Scientific Corporation | $101.82 | 2024-2025 | Moses, Lumenis Pulse 120h, Spaceoar Vue System - 10ml |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $76.81 | 2019-2021 | |
| Olympus America INC. | $76.25 | 2024-2025 | Itind System, Bovie |
| Verity Pharmaceuticals INC. | $74.80 | 2023-2025 | Tlando, Trelstar |
| Edap Technomed INC | $64.71 | 2022 | |
| Ethicon US, LLC | $59.79 | 2023 | Surgiflo Hemostatic Matrix |
| Myovant Sciences INC. | $51.07 | 2021-2022 | |
| Abbott Laboratories | $50.66 | 2021 | |
| Travere Therapeutics, INC. | $49.48 | 2019-2025 | Thiola |
| Merck Sharp & Dohme LLC | $45.38 | 2021 | |
| Ferring Pharmaceuticals INC. | $44.95 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $40.34 | 2022-2023 | Pylarify |
| Coloplast Corp | $39.58 | 2019-2024 | |
| Angiodynamics, INC. | $38.65 | 2024 | Nanoknife |
| Neotract INC. | $32.07 | 2019 | |
| Immunitybio, INC. | $27.35 | 2025 | |
| Axonics, INC. | $26.32 | 2022-2023 | Axonics |
| Civco Medical Instruments | $25.02 | 2024 | |
| Halozyme INC | $24.93 | 2023 | |
| Blue Earth Diagnostics | $24.31 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.83 | 2022 | |
| Kerecis Limited | $23.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Laborie Medical Technologies Corp. | $21.71 | 2025 | |
| Teleflex LLC | $20.44 | 2025 | Barrigel |
| Convatec INC. | $18.86 | 2021 | |
| Cycle Pharmaceuticals INC | $16.07 | 2025 | Venxxiva |
| Urovant Sciences INC | $14.02 | 2021 | |
| Metuchen Pharmaceuticals | $13.92 | 2020 | |
| Conmed Corporation | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Strang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.